| 1. |
Dai KY, Yu YC, Leu YS, et al. Neoadjuvant chemoradiotherapy and larynx-preserving surgery for cervical esophageal cancer. J Clin Med, 2020, 9(2): 387-399.
|
| 2. |
Shapiro J, van Lanschot JJB, Hulshof MCCM, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): Long-term results of a randomised controlled trial. Lancet Oncol, 2015, 16(9): 1090-1098.
|
| 3. |
Markar SR, Gronnier C, Pasquer A, et al. Role of neoadjuvant treatment in clinical T2N0M0 oesophageal cancer: Results from a retrospective multi-center European study. Eur J Cancer, 2016, 56: 59-68.
|
| 4. |
Mota FC, Cecconello I, Takeda FR, et al. Neoadjuvant therapy or upfront surgery? A systematic review and meta-analysis of T2N0 esophageal cancer treatment options. Int J Surg, 2018, 54: 176-181.
|
| 5. |
Hsu PK, Chen HS, Liu CC, et al. Neoadjuvant chemoradiation versus upfront esophagectomy in clinical stage Ⅱ and Ⅲ esophageal squamous cell carcinoma. Ann Surg Oncol, 2019, 26(2): 506-513.
|
| 6. |
Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med, 2006, 355(1): 11-20.
|
| 7. |
Ychou M, Boige V, Pignon JP, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: An FNCLCC and FFCD multicenter phase Ⅲ trial. J Clin Oncol, 2011, 29(13): 1715-1721.
|
| 8. |
Goense L, van der Sluis PC, van Rossum PSN, et al. Perioperative chemotherapy versus neoadjuvant chemoradiotherapy for esophageal or GEJ adenocarcinoma: A propensity score-matched analysis comparing toxicity, pathologic outcome, and survival. J Surg Oncol, 2017, 115(7): 812-820.
|
| 9. |
Ishihara R, Arima M, Iizuka T, et al. Endoscopic submucosal dissection/endoscopic mucosal resection guidelines for esophageal cancer. Dig Endosc, 2020, 32(4): 452-493.
|
| 10. |
Tachibana M, Kinugasa S, Shibakita M, et al. Surgical treatment of superficial esophageal cancer. Langenbecks Arch Surg, 2006, 391(4): 304-321.
|
| 11. |
Nafteux P, Depypere L, Van Veer H, et al. Principles of esophageal cancer surgery, including surgical approaches and optimal node dissection (2- vs. 3-field). Ann Cardiothorac Surg, 2017, 6(2): 152-158.
|
| 12. |
Kurokawa Y, Takeuchi H, Doki Y, et al. Mapping of lymph node metastasis from esophagogastric junction tumors: A prospective nationwide multicenter study. Ann Surg, 2019, doi: 10.1097/SLA.0000000000003499.[Epub ahead of print].
|
| 13. |
Jing SW, Qin JJ, Liu Q, et al. Comparison of neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for esophageal cancer: A meta-analysis. Future Oncol, 2019, 15(20): 2413-2422.
|
| 14. |
Ajani JA, D'Amico TA, Bentrem DJ, et al. Esophageal and esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw, 2019, 17(7): 855-883.
|
1/5
WeChat